Medtronic to acquire pain-management device maker SPR Therapeutics for $650M
Compartilhar
Medtronic (NYSE:MDT) announced a definitive agreement to acquire SPR Therapeutics, a privately held medical technology company specializing in temporary peripheral nerve stimulation (PNS) therapies for chronic pain management.
